Raleigh, NC, September 27, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, has appointed Alena Hammond as its new Global Head of Clinical Operations.
Alena Hammond is a highly accomplished professional with over 30 years of experience in the healthcare industry, with the last 25 years specializing in clinical research. Prior to joining ProPharma, she served as the Senior Vice President of Global Clinical Development Operations for Fortrea, based in Durham, North Carolina. In her new role, Alena will be responsible for overseeing and scaling clinical operations to support ProPharma's growing portfolio of global clinical trials.
"I am excited to join ProPharma and lead the Clinical Operations team," said Alena Hammond. "ProPharma has a strong reputation for excellence in the industry, and I look forward to contributing to the company's continued growth and success."
Kevin Wysocki, President of Clinical Research Solutions at ProPharma, commented: "We are delighted to welcome Alena Hammond to ProPharma. Her extensive experience and proven track record in clinical operations will be instrumental in strengthening our capabilities and expanding our global reach. Alena's leadership will be invaluable as we continue to support our clients in their critical clinical trial endeavors."
Alena Hammond's appointment marks another milestone for ProPharma as the company continues to advance its position as a leader in clinical research solutions. With her leadership, ProPharma will continue to meet the evolving needs of clients and the pharmaceutical, biotech, and medical device sectors.
